Iovance Biotherapeutics Webcasting its Analyst Day on December 13

    Author StockStreetNewsPosted on Categories Biotechnology, HealthcareTags , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

    Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) will be webcasting its Analyst Day on Wednesday, December 13 from 9:00 am to 12:00 pm EST.

    The event, being held in New York City, will highlight Iovance’s lead clinical programs. These include LN-144 for the treatment of metastatic melanoma, LN-145 for recurrent and/or metastatic squamous cell carcinoma of the head and neck, and LN-145 for recurrent, metastatic or persistent cervical cancer.

    Iovance will also be discussing the expanding clinical pipeline, strategic collaborations, and manufacturing plan for its upcoming clinical trials during the event.

    You’ll be able to find the live webcast on the investor page of Iovance Biotherapeutics’ website. The webcast will be archived for a following 30 days.

    Featured Image: Depositphotos/© photographee.eu